CompletedNot Applicable

Clinical Trial to Evaluate the Effect of a Probiotic in Acne

Spain81 participantsStarted 2020-04-29

Plain-language summary

A 12-week randomized, multicenter and double-blind, placebo-controlled study to evaluate the effect of a probiotic in the clinical and subjective evolution of acne in adolescent and adult patients.

Who can participate

Age range12 Years – 30 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Signature of informed consent by the patient (and their legal guardian in case of being under age). * Age between 12 and 30 years-old. * AGSS (Acne Global Severity Scale) Score: 2 or higher * Patients who agree to follow the study's dietary recommendations. Exclusion Criteria: * Contraindication of any of the components of the product under study. * Topical or systemic use of antifungals and antibiotics in the previous 2 weeks. * Consumption of probiotics in the previous 2 months. * Use of systemic retinoids in the previous 6 months.

What they're measuring

Change from baseline in the AGSS (Acne Global Severity Scale) index at 12 weeks

Timeframe: 0 and 12-week

Trial details

NCT IDNCT04570319

SponsorBionou Research, S.L.

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2022-07-21

View on ClinicalTrials.gov More Acne trials